WNK1 and type 2 diabetes mellitus: Interestingly, we observed that the M1808I mutation on WNK1 was significantly enriched around the phrosphorylation site Thr1810 in T2D patients, implying a pathogenic role of WNK1 in T2D via its aberrant dephosphorylation.